Last year was rough for U.S. biopharma employment. As GEN has reported, the industry announced more than 22,000 layoffs during 2013, according to Challenger Gray & Christmas, 57% more than in 2012. The next few years don’t appear to be much easier, as biopharma continues to absorb blows that include rising healthcare reform costs, continued economic weakness, and patent-cliff losses. Another potential blow to industry is price containment, if European and some Asian countries continue see little benefit from new six-figure specialty drugs, and if Washington can do more about the pricey treatments than muster up some grousing from politicians.
Yet there remain some glimmers of hope amid the gloom, namely projections for continued job growth over a decade in certain positions across U.S. biopharma. Below is a list of 10 research and clinical biotech occupations projected to add jobs through 2022, according to the U.S. Bureau of Labor Statistics’ (BLS) Occupational Outlook Handbook, 2014–15 Edition, ranked in order of the number of expected additional jobs to be created between 2012 and 2022. Each occupation also lists the number of jobs in 2012 as counted by BLS, the percentage increase between 2012 and 2022, the median pay per year in 2012, and a description of the position.